
We Need to Talk About Erectile Dysfunction: 38% of Canadian Men Don't Know You Need a Prescription for ED Medication
Article content
Article content
– This Men's Health Week, Phoenix is addressing misconceptions around erectile dysfunction to raise awareness for treatment and break the social stigma –
Article content
Article content
TORONTO — For Men's Health Week (June 9 to 15), Phoenix, Canada's leading digital health clinic for men, is raising awareness to break the stigma around erectile dysfunction (ED), a medical condition that affects almost half (49.4%) of Canadian men aged 40 to 88.
Article content
ED is a medical condition that prevents the ability to get and maintain an erection sufficient for sexual intercourse, with a range of potential causes that could each contribute to the condition, including age, medications, injury, and lifestyle. Despite its prevalence, Phoenix's survey of more than 1,500 Canadians found that there is a significant lack of awareness around ED and its treatment, likely contributing to stigma surrounding the condition.
Article content
CANADIANS UNDERESTIMATE THE REACH OF ED
Article content
Despite nearly half of Canadian men over 40 being affected, ED's prevalence is underestimated, driving undue stigma. In fact, almost half of Canadians (45%) think that ED affects less than 40 per cent of men 40+. Twenty-seven per cent of Canadians think it affects less than 30 per cent of men 40+.
Article content
While Canadians underestimate the prevalence of ED in middle-aged and older men, many are also unaware that the condition can also impact younger men. The survey found that 64 per cent of Canadians don't know that men aged 35 and younger can experience ED. That percentage grows as you look at younger men, with 71% of Canadians unaware that men aged 18 to 25 can be affected. This common misconception can contribute to the stigma around experiencing ED as a younger man, making it more difficult for those struggling to seek care.
Article content
'ED is a medical condition that men of all ages can experience. There shouldn't be anything awkward about it, but there is. We're trying to change that,' says Kevin Bache, co-founder and co-CEO of Phoenix. 'While it may feel uncomfortable, men need to understand what the condition entails, and not shy away from being proactive in discussing it with a doctor. The sooner you get started, the better your chances are at finding mental and physical relief.'
Article content
Treatment for ED and its underlying cause can vary greatly depending on a patient's prognosis, however, medication is a common and effective treatment. Despite this fact, Phoenix's survey found 18 per cent of men are unsure if ED is treatable with medication, revealing a lack of awareness that may leave many suffering needlessly.
Article content
The data also highlighted a concerning gap in awareness that ED medication requires a prescription
Article content
. Thirty-eight per cent of men are unsure or don't think they need a prescription to purchase medication, such as Viagra, for ED. However, the lack of awareness is most significant among younger Canadians.
Article content
About three in five
Article content
Gen Z (59%) don't know that you need a prescription for ED medication:
Article content
32 per cent are unsure, and 27 per cent don't think you need a prescription at all.
Article content
It is important that Canadians know that ED medication requires a prescription from a medical professional, as they may otherwise be vulnerable to purchasing unauthorized sexual enhancement products sold over the counter, which Health Canada warns could pose serious health risks.
'It's no surprise that people aren't aware of the prevalence of ED – it just doesn't get talked about enough. But the good news is, there are treatment options, and with more openness and awareness, more people can seek support immediately,' says Gavin Thompson, co-founder and co-CEO of Phoenix. 'We built Phoenix to change that. Our mission is simple: make expert care easy to access – fast, discreet, and doctor-led. We're building a future where men take charge of their health with confidence.'
Article content
WHAT CANADIANS NEED TO KNOW ABOUT ED
Article content
ED can affect men at any age, but it becomes more common as you get older.
ED is more common than you may think, affecting almost half of Canadian men aged 40 to 88.
Many factors can cause ED, including: low levels of testosterone, nervous dysfunction, blood flow complications, medications, medical conditions, lifestyle factors, obesity, diet, drug abuse, smoking, and emotional or psychological complications.
ED is highly treatable, but the first step is consulting a medical professional. Treatment for erectile dysfunction and its underlying cause can vary greatly, making it important to consult a medical professional to receive a diagnosis and devise an effective treatment strategy.
ED medication requires a prescription from a medical professional.
Article content
Phoenix is currently available in Ontario, Alberta, British Columbia, Saskatchewan, Manitoba, Nova Scotia, New Brunswick, PEI, and Newfoundland. To learn more about Phoenix's ED support, visit https://www.phoenix.ca/treatments/erectile-dysfunction.
Article content
ABOUT PHOENIX
Article content
Phoenix is Canada's leading digital health clinic for men, specializing in three areas of treatment – erectile dysfunction, weight loss, and hair loss. The telehealth platform facilitates access to licensed Canadian physicians, treatment options, and free, discreet shipping of prescription medication from coast to coast. Visit Phoenix.ca to learn more.
Article content
SURVEY METHODOLOGY
Article content
These findings are from a survey conducted by Phoenix from May 20th to May 22nd, 2025, among a representative sample of 1509 online Canadians who are members of the Angus Reid Forum. The survey was conducted in English and French. For comparison purposes only, a probability sample of this size would carry a margin of error of +/-2.53 percentage points, 19 times out of 20.
Article content
Article content
Article content
Article content
Article content
Contacts
Article content
MEDIA
Article content
Article content
Article content
Article content
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

CBC
26 minutes ago
- CBC
Sudbury long-term care home still can't admit new residents, six months after provincial order issued
Social Sharing A long-term care home in Sudbury has not been able to admit new residents for six months now, following a provincial order. The Ontario Ministry of Long Term Care issued what it calls a Cease Admissions Order on December 16, 2024. This means no new residents can move into the nursing home while the order remains in place. The order came after residents and families made numerous complaints about care at the home, which opened in May 2024 on Algonquin Road in the city's south end. Provincial inspectors issued six compliance orders after finding standards were not being met under Ontario's Fixing Long-Term Care Act. The those orders have since been lifted, but follow-up inspections at Extendicare Countryside since December have found some of the same issues are ongoing. The latest inspection report published by the ministry on June 4 comes from an on-site inspection between May 5 and May 9. These types of inspections are regular check-ins to identify any non-compliance with provincial standards and do not cover complaints or critical issues, which are investigated separately. Following the inspection, five written notifications were given to Extendicare Countryside for non-compliance. These include issues with skin and wound care, including failing to ensure that the care a resident received was documented. The home was also notified about staff not responding to the needs of a resident and not properly cleaning the dining area. In a statement to CBC News, Extendicare Countryside said the written notifications "are not unexpected or unusual for any Ontario long-term care home. This is helpful feedback that allows us to focus on areas that require additional effort or improvement." Extendicare added it continues to address gaps and improve care and is encouraged by the home's continued progress. Despite that, families and residents have continued to voice their concerns in recent months, with Sudbury-area New Democrat MPPs Jamie West and France Gélinas calling for a full inspection of the nursing home.


Globe and Mail
42 minutes ago
- Globe and Mail
Analysts Say AI Could Add $100B+ to Healthcare—But Most Systems Aren't Ready
Issued on behalf of Avant Technologies Inc. VANCOUVER – News Commentary – A growing chorus of political and academic voices is calling AI the defining force behind the next evolution in healthcare. Former UK Prime Minister Tony Blair recently warned that failing to embrace AI-driven doctors and nurses could leave entire nations behind, while London Business School professor Nicos Savva echoed the sentiment in Forbes, framing AI as essential to future-ready care. Meanwhile, a new Wolters Kluwer report highlights a troubling disconnect: while interest is surging, most healthcare organizations remain unprepared to deploy GenAI tools at scale. Yet even as institutions scramble to catch up, key breakthroughs are already coming from innovators like Avant Technologies, Inc. (OTCQB: AVAI), Palantir Technologies (NASDAQ: PLTR), Astrana Health, Inc. (NASDAQ: ASTH), Tempus AI, Inc. (NASDAQ: TEM), and SoundHound AI, Inc. (NASDAQ: SOUN). Analysts at McKinsey now estimate that generative AI could generate up to $110 billion in annual value across pharma and medical products alone. Statista projects the broader AI healthcare market will surge from $11 billion today to $188 billion by 2030 — a leap that signals just how quickly the landscape is changing. Avant Technologies, Inc. (OTCQB: AVAI) has just taken a major step forward in its evolution from AI incubator to full-stack healthcare innovator. Today, the company announced it had signed a non-binding letter of intent to acquire 100% of Ainnova Tech, its joint venture partner and the developer of the Vision AI diagnostic platform. Prior to the acquisition, the two companies have been operating jointly through Ai-nova Acquisition Corp (AAC), which holds global licensing rights to Ainnova's technology portfolio and serves as the commercialization engine for Vision AI and all future device deployments. 'We believe bringing the two companies together will offer tremendous value for shareholders, it will simplify the process of advancing our technology to market, and it will deliver value to our customers and partners as we promote our technology portfolio globally,' said Vinicio Vargas, CEO at Ainnova and a member of the Board of Directors of AAC. 'We feel the joint venture has been a success and both companies have worked well together toward a common goal, so we believe that we can be even more successful and use our resources more effectively as one company to further AI in healthcare.' Under the proposed agreement, Ainnova would roll all of its outstanding equity into the combined public entity — unifying leadership and eliminating structural complexity ahead of a scheduled FDA pre-submission meeting in July. While final terms of the deal are still being negotiated, both companies say the merger would streamline commercialization and accelerate the rollout of Ainnova's flagship Vision AI technology — a platform already in use across clinical sites in Latin America for the early detection of diabetic retinopathy, cardiovascular disease, and other chronic conditions. The move also signals growing confidence from Avant's leadership as they prepare to bring proprietary hardware into the mix. In parallel with the merger discussions, Avant and Ainnova are entering the final prototyping stage of a low-cost, automated retinal imaging device — marking a potential turning point in the companies' shared push toward AI-powered early diagnostics. The new device is designed to operate hands-free and feed imaging data directly into the Vision AI platform, enabling near-instant risk reports without expensive equipment or trained personnel. The companies say the camera, developed under their joint venture Ai-nova Acquisition Corp. (AAC), is expected to cost a fraction of legacy fundus cameras. By combining affordability with automation, the device could expand screening access across primary care clinics and emerging-market providers that have traditionally been priced out of ophthalmic diagnostics. 'The cost of a fundus camera has always been a barrier to entry in this market,' said Vargas. 'Our low-cost camera, which is a fraction of the cost of currently available cameras on the market, should allow us to not only enter the market, but to capture a large share of the market.' Also in development are additional platform modules, including a patented dementia detection tool that combines a five-minute blood test with AI-trained algorithms. Although that technology remains in evaluation, the core platform continues to expand its reach and functionality — evolving from a retinal-focused application into a broader engine for predictive healthcare. 'Our purpose is to create the future of early disease detection in an accessible way, so that patients can get a preventive check-up anywhere, at a low cost, and easily,' said Vargas in a previous statement. 'We want to prevent patients with risk factors from developing other diseases that could have been avoided before they became a real problem. To this end, we are seeking to integrate new technologies into our portfolio within a single platform, both through our R&D efforts and through potential exclusive licenses or acquisitions.' As the camera prototype nears completion, Avant is positioning itself for broader market entry. While a launch date has yet to be announced, the integrated platform is designed to reduce diagnostic friction, speed up referrals, and expand access to early-stage health insights — especially in geographies where affordability, not innovation, remains the primary barrier to care. Palantir Technologies (NASDAQ: PLTR) has partnered with TeleTracking Technologies to bring real-time AI-driven insights to hospitals and health systems. 'This partnership with TeleTracking represents the AI revolution in healthcare we are in the midst of—where we continue to move closer to a world where all hospitals and health systems are embracing, implementing and operating with an AI-powered approach,' said Alex Karp, CEO at Palantir. 'Helping to streamline operations allowing for increased focus on providing the best level of care.' By integrating TeleTracking's Operations IQ platform with Palantir's Foundry and AIP tools, the collaboration will enable smarter resource management, predictive forecasting, and near-instant operational decision-making. The combined platform is designed to improve patient flow, reduce staff burden, and drive measurable gains in both care outcomes and financial performance. Astrana Health, Inc. (NASDAQ: ASTH) recently announced a wave of leadership appointments as the company accelerates its national rollout of an AI-driven, value-based care model. The most notable addition is Sherry McBride, a seasoned Medicare Advantage operator who joins as COO to lead integration and execution across Astrana's growing platform. 'We are thrilled to welcome Sherry, along with other recent executive hires and promotions, to the leadership team at a time of immense growth and opportunity for Astrana,' said Brandon Sim, President and CEO of Astrana Health. 'Her deep experience in delegated value-based care will further strengthen our ability to drive consistent, coordinated, high-quality patient outcomes at scale.' Other hires include a new Chief Data and Analytics Officer, Chief Accounting Officer, and Chief People Officer — a signal of Astrana's broader push to deepen capabilities across every operational tier. With a footprint spanning over 12,000 providers and more than a million patients, Astrana is preparing to scale smart, coordinated care on a national level. Tempus AI, Inc. (NASDAQ: TEM) has expanded its generative AI clinical assistant, Tempus One, with direct integration into EHR systems, allowing physicians to query data and streamline workflows in real time. 'As healthcare faces rising costs and growing complexity, no group bears the burden more heavily than physicians and care teams,' said Ryan Fukushima, Chief Operating Officer at Tempus. 'This evolution of Tempus One represents a meaningful shift from a world where clinicians spend countless hours searching for answers and documenting care, to one where AI rapidly connects the dots across fragmented systems to deliver actionable insights in real time.' The platform now includes embedded ASCO guidelines, appointment prep tools, and intelligent note-taking — reducing administrative burden and improving decision-making in oncology and beyond. Tempus is also rolling out its Agent Builder tool to select providers, enabling custom GenAI solutions integrated directly into clinical practice. SoundHound AI, Inc. (NASDAQ: SOUN) has partnered with Allina Health to launch 'Alli,' an AI-powered voice agent designed to streamline patient access and reduce administrative bottlenecks. "One of our key goals is to make sure that we're providing a market-leading patient experience," said David Ingham, DO, Chief Information Officer of Allina Health. "Alli is an extension of our team, and we're excited to have her on board to streamline operations, reduce wait times, and deliver a faster, more seamless experience for our patients." Built on the Amelia conversational AI platform, Alli integrates with Allina's EHR system to authenticate callers, manage appointments, and soon handle tasks like refilling medications or answering non-clinical questions. "Long wait times and administrative complexity can be a huge source of stress for patients," said Michael Anderson, Executive Vice President of Enterprise AI at SoundHound AI. "We are proud to partner with Allina Health on this important digital transformation. The organization is taking a forward-thinking approach by integrating AI to support patients with immediate, personalized assistance." Early results show improved call efficiency and faster response times, enabling staff to focus on complex patient needs. CONTACT: cs@ (250) 999-4849 DISCLAIMER: Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. is a wholly-owned subsidiary of Media Corp. ('BAY') BAY has been not been paid a fee for Avant Technologies Inc. advertising and/or digital media, but the owner(s) of BAY also own Market IQ Media Group, Inc., which has been paid a fee from the company directly. There may be 3rd parties who may have shares Avant Technologies Inc., and may liquidate their shares which could have a negative effect on the price of the stock. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this publication as the basis for any investment decision. The owner/operator of BAY own shares of Avant Technologies Inc. which were purchased in the open market. BAY and all of it's respective employees, owners and affiliates reserve the right to buy and sell, and will buy and sell shares of Avant Technologies Inc. at any time thereafter without any further notice. We also expect further compensation as an ongoing digital media effort to increase visibility for the company, no further notice will be given, but let this disclaimer serve as notice that all material disseminated by BAY has been approved by the above mentioned company; this is a paid advertisement, and we own shares of the mentioned company that we will sell, and we also reserve the right to buy shares of the company in the open market, or through other investment vehicles. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

National Post
43 minutes ago
- National Post
Nearly Three in Four Ontarians Want Provincial Government to Prioritize Spending on Public Hospitals Instead of Private Clinics: New Poll
Article content OTTAWA, Ontario — Seventy-three per cent of Ontarians believe the government should prioritize spending on public hospitals rather than private clinics, in a poll conducted following the recent budget announcement of $280 million being shunted to private, for-profit clinics. Eighty-four per cent also said they believe public hospitals are understaffed. Article content The Nanos Poll was conducted between May 27 and June 1, surveying 1,017 Ontarians over the age of 18. The poll was commissioned by CUPE's Ontario Council of Hospital Unions (OCHU-CUPE), which released a supplementary report on the ongoing privatization of hospital services. 'This poll shows there is overwhelming opposition to this government's plans to privatize hospital surgeries,' said Michael Hurley, president of OCHU-CUPE, which represents 50,000 hospital and long-term care staff. 'The public understands that spending on private, for-profit clinics and agencies is much more expensive, comes with poorer outcomes and duplicates infrastructure and administration. The vast majority wants our resources allocated to public health care.' Article content While the government expands funding to for-profit clinics, over four in five Ontarians (84%) believe there is not enough staff in public hospitals – including 82 per cent of Ontario PC supporters. Article content In the recent budget health care funding increased two per cent, well below the annual health care inflation of 5.2 per cent, noted the union. Article content After significant privatization of cataract surgeries, the government plans to expand private, for-profit delivery of other procedures including knee and hip replacements as well as diagnostics. In 2023, Premier Doug Ford suggested that up to 50 per cent of surgeries could be performed outside of hospitals. Article content 'This is startling given that for-profit surgeries in Ontario are twice as expensive as those performed in public hospitals,' said Hurley. Article content The OCHU-CUPE report highlights the findings of a 2024 Canadian Medical Association Journal study showing that privatization of cataract operations resulted in surgical rates increasing by 22 per cent for the wealthiest Ontarians while declining for everyone else. Access to surgeries for the poorest people in Ontario declined nine per cent. The study noted that hospitals provided equal access to care. Article content At the media conference, the union showed a visual representation of this inequality through a map of Ottawa's neighbourhoods, colour-coded by socioeconomic status. Article content 'People can't afford to pay thousands of dollars for health care,' Hurley said. 'The great majority of Ontarians reject this expensive privatization that bakes in inequalities and greatly reduces access.' Article content The Ontario Health Coalition has documented hundreds of cases of private, for-profit clinics billing patients for medically necessary services – which is illegal – and add-on services that patients felt compelled to purchase. Article content Sixty-seven per cent of respondents to the Nanos poll said it was unacceptable for private clinics to charge people for medically necessary services. Article content The union expressed concerns about the acceleration of privatization, citing the CMAJ study's findings showing that since expansion of public funding for cataract surgeries in Ontario, 22.5 per cent of these procedures were performed in private clinics. Article content Summary of survey results: Article content Article content Article content Article content Article content Contacts Article content For more information please contact: Article content Article content Article content Article content